These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20570406)

  • 1. ω-3 fatty acids and cognitive decline: modulation by ApoEε4 allele and depression.
    Samieri C; Féart C; Proust-Lima C; Peuchant E; Dartigues JF; Amieva H; Barberger-Gateau P
    Neurobiol Aging; 2011 Dec; 32(12):2317.e13-22. PubMed ID: 20570406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men.
    Plourde M; Vohl MC; Vandal M; Couture P; Lemieux S; Cunnane SC
    Br J Nutr; 2009 Oct; 102(8):1121-4. PubMed ID: 19828088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.
    Sinn N; Milte CM; Street SJ; Buckley JD; Coates AM; Petkov J; Howe PR
    Br J Nutr; 2012 Jun; 107(11):1682-93. PubMed ID: 21929835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery disease.
    Freiheit EA; Hogan DB; Eliasziw M; Patten SB; Demchuk AM; Faris P; Anderson T; Galbraith D; Parboosingh JS; Ghali WA; Knudtson M; Maxwell CJ
    Arch Gen Psychiatry; 2012 Mar; 69(3):244-55. PubMed ID: 22393217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe.
    Samieri C; Maillard P; Crivello F; Proust-Lima C; Peuchant E; Helmer C; Amieva H; Allard M; Dartigues JF; Cunnane SC; Mazoyer BM; Barberger-Gateau P
    Neurology; 2012 Aug; 79(7):642-50. PubMed ID: 22855869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary cortisol, APOE-ε4 allele and cognitive decline in a prospective study of older persons.
    Gerritsen L; Comijs HC; Deeg DJ; Penninx BW; Geerlings MI
    Neurobiol Aging; 2011 Sep; 32(9):1615-25. PubMed ID: 19879666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
    van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG
    Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study.
    Irving GF; Freund-Levi Y; Eriksdotter-Jönhagen M; Basun H; Brismar K; Hjorth E; Palmblad J; Vessby B; Vedin I; Wahlund LO; Cederholm T
    J Am Geriatr Soc; 2009 Jan; 57(1):11-7. PubMed ID: 19054188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis.
    Shi J; Tu JL; Gale SD; Baxter L; Vollmer TL; Campagnolo DI; Tyry TM; Zhuang Y; Kuniyoshi SM
    Cogn Behav Neurol; 2011 Sep; 24(3):128-33. PubMed ID: 21945984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The apolipoprotein E epsilon4 allele is not associated with cognitive dysfunction in cardiac surgery.
    Silbert BS; Evered LA; Scott DA; Cowie TF
    Ann Thorac Surg; 2008 Sep; 86(3):841-7. PubMed ID: 18721571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic markers of inflammation and cognitive decline in old age.
    Schram MT; Euser SM; de Craen AJ; Witteman JC; Frölich M; Hofman A; Jolles J; Breteler MM; Westendorp RG
    J Am Geriatr Soc; 2007 May; 55(5):708-16. PubMed ID: 17493190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
    van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
    Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
    Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
    Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.
    Lopez OL; Jagust WJ; Dulberg C; Becker JT; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Jones B; Kawas C; Carlson M; Kuller LH
    Arch Neurol; 2003 Oct; 60(10):1394-9. PubMed ID: 14568809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.